GYRE logo

Gyre Therapeutics (GYRE) Selling, General & Administrative Expenses

Annual SGA

$75.82 M
+$4.21 M+5.88%

December 31, 2023


Summary


Performance

GYRE SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGYREexpensesmetrics:

Quarterly SGA

$17.52 M
-$316.00 K-1.77%

September 30, 2024


Summary


Performance

GYRE Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGYREexpensesmetrics:

TTM SGA

-$311.38 M
-$73.35 M-30.82%

September 30, 2024


Summary


Performance

GYRE TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherGYREexpensesmetrics:

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

GYRE Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+5.9%-33.9%-510.7%
3 y3 years+56.9%+20.8%-2246.4%
5 y5 years+56.9%+20.8%-2246.4%

GYRE Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+56.9%-33.9%+27.3%-769.6%at low
5 y5-yearat high+56.9%-33.9%+27.3%-769.6%at low
alltimeall timeat high+56.9%-33.9%+27.3%-769.6%at low

Gyre Therapeutics Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sep 2024
-
$17.52 M(-1.8%)
$77.82 M(+3.2%)
Jun 2024
-
$17.84 M(+11.9%)
$75.38 M(-2.4%)
Mar 2024
-
$15.94 M(-39.9%)
$77.25 M(+1.9%)
Dec 2023
$75.82 M
$26.52 M(+75.8%)
$75.82 M(+53.8%)
Sep 2023
-
$15.09 M(-23.5%)
$49.30 M(+44.1%)
DateAnnualQuarterlyTTM
Jun 2023
-
$19.71 M(+35.9%)
$34.22 M(+135.9%)
Mar 2023
-
$14.51 M(+5.4%)
$14.51 M(+5.4%)
Dec 2022
$71.61 M(+48.2%)
-
-
Mar 2022
-
$13.76 M
$13.76 M
Dec 2021
$48.33 M
-
-

FAQ

  • What is Gyre Therapeutics annual SGA?
  • What is the all time high annual SGA for Gyre Therapeutics?
  • What is Gyre Therapeutics annual SGA year-on-year change?
  • What is Gyre Therapeutics quarterly SGA?
  • What is the all time high quarterly SGA for Gyre Therapeutics?
  • What is Gyre Therapeutics quarterly SGA year-on-year change?
  • What is Gyre Therapeutics TTM SGA?
  • What is the all time high TTM SGA for Gyre Therapeutics?
  • What is Gyre Therapeutics TTM SGA year-on-year change?

What is Gyre Therapeutics annual SGA?

The current annual SGA of GYRE is $75.82 M

What is the all time high annual SGA for Gyre Therapeutics?

Gyre Therapeutics all-time high annual SGA is $75.82 M

What is Gyre Therapeutics annual SGA year-on-year change?

Over the past year, GYRE annual SGA has changed by +$4.21 M (+5.88%)

What is Gyre Therapeutics quarterly SGA?

The current quarterly SGA of GYRE is $17.52 M

What is the all time high quarterly SGA for Gyre Therapeutics?

Gyre Therapeutics all-time high quarterly SGA is $26.52 M

What is Gyre Therapeutics quarterly SGA year-on-year change?

Over the past year, GYRE quarterly SGA has changed by -$9.00 M (-33.93%)

What is Gyre Therapeutics TTM SGA?

The current TTM SGA of GYRE is -$311.38 M

What is the all time high TTM SGA for Gyre Therapeutics?

Gyre Therapeutics all-time high TTM SGA is $46.50 M

What is Gyre Therapeutics TTM SGA year-on-year change?

Over the past year, GYRE TTM SGA has changed by -$387.20 M (-510.67%)